Skip to content

Does low testosterone cause hair loss, and does TRT speed it up? The DHT story, graded by the evidence

By the TRT Clarity editorial team Published 8 sources How we verify

A wooden wide-tooth comb resting on a folded dark towel on a walnut surface, its teeth edge-lit in teal against a dark background.

The short answer

As of

Low testosterone does not cause male pattern baldness; it is more likely to thin body hair. Pattern baldness is driven by DHT, made from testosterone, acting on genetically sensitive follicles. TRT may add to it in men already prone, but the evidence linking the two is weak. Finasteride and minoxidil are the usual responses.

Two worries pull in opposite directions. Some men think their thinning hair means their testosterone is low. Others are about to start TRT and fear it will make them bald. Both worries come from a real link between hormones and hair, but they get the direction wrong. This page walks through what the research shows on low testosterone, TRT and the hormone that actually drives pattern baldness, DHT, and what men on TRT do about their hair.

Does low testosterone cause hair loss?

Low testosterone does not cause male pattern baldness, the receding hairline and thinning crown most men mean by “hair loss.” Pattern baldness needs androgens to develop: historically, castrated men did not develop it unless they were given testosterone, and studies measuring blood testosterone have failed to show a reproducible difference between bald men and men with full hair (Asfour, Cranwell and Sinclair, Endotext, 2023). The same review notes that normal androgen levels are enough to cause hair loss in men who are genetically susceptible. The evidence level here is decades of observational and clinical research summarized in an endocrinology textbook, not a single trial.

Can low testosterone cause hair loss on the body?

Yes, and this is the hair change that does point to low testosterone. The Endocrine Society’s guideline on testosterone therapy lists loss of body hair, specifically underarm and pubic hair, among the more specific signs of testosterone deficiency in men (Bhasin et al., Endocrine Society guideline, 2018). So a man with low T is more likely to notice thinner body hair than a balding scalp. Our guide to low testosterone symptoms covers the full list and the bloodwork that confirms it.

The DHT story: what actually drives male pattern baldness

Male pattern baldness is a mix of genes and one hormone in particular. It affects 30 to 50% of men by age 50, and heredity accounts for roughly 80% of the predisposition (Asfour et al., Endotext, 2023). The hormone is dihydrotestosterone (DHT). An enzyme called 5-alpha reductase converts testosterone into DHT, and DHT binding to androgen receptors in scalp hair follicles produces the condition. The clearest natural experiment: men born with 5-alpha reductase deficiency, who cannot make much DHT, do not go bald (same source).

DHT binds the androgen receptor with roughly five times the affinity of testosterone, which is why researchers see it as the key driver, according to a 2024 dermatology review (Tawanwongsri et al., Int J Dermatol, 2024). Over time, affected follicles shrink with each growth cycle until the hairs they produce are too short and fine to cover the scalp. Once follicles have fully miniaturized, the loss is likely irreversible (Asfour et al., Endotext, 2023).

That is the whole puzzle in one line: the testosterone number in your blood matters less than how your scalp follicles respond to DHT, and that response is mostly inherited.

Does TRT cause hair loss?

TRT may contribute to pattern hair loss in some men, but the evidence on men treated for low testosterone is weak and thin. The Endocrine Society lists familial male pattern balding among the uncommon adverse events with weak evidence of an association with testosterone treatment (Bhasin et al., 2018). A 2026 systematic review of androgen supplementation and hair loss included 14 studies with 2,344 people and found that hair loss outcomes in androgen-deficient men, the TRT population, were simply not available (Gupta et al., JAAD International, 2026).

What the review did find comes from neighboring groups:

  • Transgender men starting testosterone: pattern hair loss rose from 1.9% at baseline to 19.5% over follow-up.
  • Men using anabolic steroids: alopecia rose from 2% to 12% after 2 to 52 weeks of use, in a study of 100 men.
  • Men who already had pattern hair loss and applied topical testosterone in experimental trials: after 6 weeks, 16.3% reported worse hair loss, 17.3% improvement, and 66.3% no change.

The authors call the evidence heterogeneous, with small samples and self-reported outcomes. None of these groups is a man with diagnosed low T restoring his levels to the normal range, so the numbers show direction, not a TRT-specific risk. The 2024 review reached a similar conclusion for performance users: studies on testosterone and hair rely mostly on self-reports, and more research is needed to clarify the relationship (Tawanwongsri et al., 2024).

Is hair loss on TRT permanent?

The research reviewed here has no data on men who lost hair on TRT and then stopped, so there is no TRT-specific answer. What is known applies to pattern hair loss in general: the treatments slow or partly reverse it only while you keep taking them, and once follicles have fully miniaturized the loss is likely permanent (Asfour et al., Endotext, 2023).

Low T vs TRT vs DHT: how each affects hair

Low testosterone mainly affects body hair, DHT drives scalp pattern loss, and TRT sits in between, with the weakest evidence of the three. The table sets them side by side with the strength of the evidence for each.

How low testosterone, TRT and DHT relate to hair, with the strength of the evidence for each.
Attribute Low testosterone TRT DHT
What it is Testosterone below the normal range Testosterone given to restore normal levels A more potent androgen made from testosterone by 5-alpha reductase
Effect on scalp hair Not a cause of pattern baldness May add to pattern loss in men already prone The main hormonal driver of pattern baldness
Effect on body hair Can thin underarm and pubic hair Not studied for hair in men with low T Not covered by the sources on this page
Evidence level Guideline-listed sign; observational data on scalp hair Weak; data come from trans men, steroid users and small trials Strong; genetic, observational and drug-trial evidence
What changes it Treating the underlying deficiency Your inherited sensitivity; the role of dose is unstudied Finasteride and dutasteride lower it

What do men on TRT do about hair loss?

There is no TRT-specific hair treatment; the options are the ones used for pattern hair loss in general. The two with FDA approval for male pattern hair loss are topical minoxidil and oral finasteride; both slow further loss, only partly reverse it, and need continuous use (Asfour et al., Endotext, 2023). Combining drugs that work by different mechanisms improves results, according to the same review. A 2024 review notes that studies are lacking on how well finasteride and minoxidil work in men using anabolic steroids, especially at high testosterone doses, so it is uncertain whether results match those in other men (Tawanwongsri et al., 2024).

Can you take finasteride while on TRT?

The pairing has not been tested for hair in men treated for low T, but a randomized trial found that blocking DHT did not blunt testosterone’s main effects. Finasteride blocks type II 5-alpha reductase; at the 1 mg daily dose studied for hair loss it cuts scalp DHT by 64% and blood DHT by 68% (Asfour et al., Endotext, 2023). In two one-year trials in 1,553 men aged 18 to 41, with 1,215 continuing for a second year, finasteride slowed hair loss and increased hair growth compared with placebo (Kaufman et al., J Am Acad Dermatol, 1998).

The question men on TRT ask is whether lowering DHT costs them the benefits of testosterone. A randomized trial gave healthy men aged 18 to 50 (139 randomized, 102 completed) graded testosterone doses for 20 weeks, with or without dutasteride, a drug that blocks both forms of 5-alpha reductase. Gains in fat-free mass did not differ between the groups, and neither did muscle strength, sexual function scores or red blood cell levels (Bhasin et al., JAMA, 2012). The trial did not measure hair. The authors also cautioned that older men with low testosterone, the likely users of these drugs, may be at risk of erectile dysfunction on 5-alpha reductase inhibitors. Sexual side effects of finasteride are uncommon and usually resolve, while reports of permanent effects circulate on social media and forums with an unknown true incidence (Asfour et al., Endotext, 2023). Complexion Science covers the pairing in oral minoxidil and finasteride.

Does minoxidil work for men on TRT?

Minoxidil has not been studied in men on TRT specifically. It works by a different route from finasteride rather than by lowering DHT, which is why the two can be combined. Topical minoxidil is FDA-approved for male pattern hair loss. Oral minoxidil, a blood-pressure tablet, is used off-label at low doses (Asfour et al., Endotext, 2023). Its evidence level is one head-to-head randomized trial plus large observational safety data:

  • In a double-blind trial of 90 men with pattern hair loss, daily oral minoxidil was not superior to twice-daily 5% topical minoxidil after 24 weeks, though photo assessment favored the oral form on the crown. In the oral group, 49% had unwanted body or facial hair growth (hypertrichosis) and 14% had headaches (Penha et al., JAMA Dermatology, 2024).
  • A multicenter study of 1,404 patients on low-dose oral minoxidil found hypertrichosis in 15.1%, lightheadedness in 1.7%, fluid retention in 1.3% and a fast heart rate in 0.9%; 1.7% stopped because of side effects, and no life-threatening effects were seen (Vañó-Galván et al., J Am Acad Dermatol, 2021).

Complexion Science goes deeper in oral minoxidil for hair loss and oral minoxidil side effects.

What does hair loss treatment cost on TRT?

The main cost is time: every option on this page works only while you keep using it, so hair treatment becomes a second monthly line item alongside TRT (Asfour et al., Endotext, 2023). Prices for finasteride, topical minoxidil and oral minoxidil vary by pharmacy, insurance and whether the product is brand, generic or compounded, and we have not verified current list prices, so we do not print any. For what TRT itself costs, see our TRT cost guide.

Myth vs evidence: what the hair-loss conversation gets right and wrong

Our Community Insights samples do not yet cover hair loss on TRT, so there are no community quotes on this page. Four familiar claims can still be checked against the research:

  • “Thinning hair means low T.” Not supported. Blood testosterone does not reliably differ between bald men and others, and body hair, not scalp hair, is the guideline-listed sign of deficiency.
  • “TRT will make you bald.” Overstated. Testosterone can feed pattern loss in men who are genetically prone, but the data on men treated for low T are missing, and the guideline grades the link as weak.
  • “Block DHT and you lose your gains.” Not supported in a randomized trial that tested it: fat-free mass and strength gains on testosterone did not change with dutasteride.
  • “Finasteride always wrecks your sex life.” Overstated, but not baseless. Sexual side effects are uncommon and usually resolve; reports of lasting effects exist, and their true frequency is unknown.

Men weighing TRT alongside other options can compare them in our guide to peptides for men, which grades oral minoxidil next to the other substances men use.

Status (oral minoxidil): Active ingredient is FDA-approved; compounded versions are not FDA-approved, and use for hair loss is off-label. What these status terms mean.

Educational information only, not medical advice. Statements on this page are sourced to the Endocrine Society guideline, the Endotext chapter on male androgenetic alopecia, and the peer-reviewed trials and reviews linked above. Updated October 12, 2026. This page is drafted with AI assistance and fact-checked against the cited primary sources before publication.

Sources (8)

  1. 1
    NCBI

    /sites/books/NBK278957

  2. 2
    Oxford Academic

    /jcem/article/103/5/1715/4939465

  3. 3
    PubMed Central

    PMC13099485

  4. 4
    PubMed Central

    PMC11931090

  5. 5
    JAMA Network

    /journals/jama/fullarticle/1105045

  6. 6
    PubMed

    PMID 9777765

  7. 7
    PubMed Central

    PMC11007651

  8. 8
    jaad.org

    /article/S0190-9622(21)00418-7/abstract

Advertising disclosure: links marked "Paid link" go to Bodybuilding Peptides (trybbpeptides.com), an affiliate destination, and TRT Clarity may earn a commission if you buy there. Our coverage is independent of that relationship, and nothing on this page is medical or legal advice.

See it at Bodybuilding Peptides (opens in a new tab)

Paid link